PER

0.00%

10.0¢ percheron therapeutics limited

Ann: Investor Presentation, page-15

First 15 Last

Share
Profile

Follow
phlipper

420 Posts.

471

19/11/20

07:36

Post #: 48976033
Share

Originally posted by samfiodiving: ↑

Was this insider webinar meant to target investors or what

How can anyone rate this as good i will never know

Diamond kicks in by saying we are looking at advancing our pipeline of drugs we have two compounds we call them ATl1101 and Atl1102 multiple successful Ph2 trials ( REALLY what a F#N Joke this guy is )

ATL1101 my ass

Todays presentation he is going to focus on ATL1102 ( WHY 1102 is this an investment seminar or not )

His presentation itself on DMD was not that bad, but in all fairness is should be outstanding the number of times he has presented this, it should be flawless

so lets move past the dmd preso and onto

near and medium term value drivers

40min mark for me the whole thing falls apart, his mouse movements are as erratic as his speech

Talks on near term drivers yet refuses to talk on ATL1103,is it a near term driver or not ( don't you think this would be of major interest to the potential investors listening to this, if near term we are going to partner ATL1103 What a joke this guy is )

40.45sec summary ad value drivers

( once again totally ignores ATL1103 and its partnering unbelievable)

42min questions

question asked on companion therapy and partnering

well this investor must have had no clue at the end of Diamonds answer

Talk about rambling on

I presume because there was a mention of joint therapy the question was directed at would we possibly be looking at partnering/collaborating with any of the dystrophy pharma's in the DMD field

Diamond went of on a stuttering rant to goodness knows where it was embarrassing to say the least and as an investor please DO NOT MEINTION the word PARTNERING it would appear its a taboo word and only talked about in the inner circles.

I understand time was a restraint but if you are looking to investors to invest, you don't side step what could turn out to be a major milestone in the possible partnering near term of Atl1103

some time should have been spent on its promotion

Sorry another fail for mine

On a side note nothing in the the request for loyalty options in the AGM as in no resolution put forward

This path is reminiscent of the Pattos days CR tap the big boys when required and let the long term suffering shareholders do exactly that suffer

The thing that got me, Diamond was basically boasting that he had gotten rid of the overhang from AEF in a X trade

our number 1 holder

These people at one stage had over 70mil shares in ANP and this guy is glad to see the back of them

OR WAS IT THE OTHER WAY AROUND

WHAT these people put us where we sit today and he is glad they are gone

No one has actually bothered to ask this

but this fund in AEF did their DD when they got onboard, has anyone here thought to ask

WHY

WHY have they left the building if we have so much potential

Is it because they could see our CEO could not PROMOTE a free P!$$ up in a brewery

Good question i think and one all shareholders should be mindful of

Not sure if i will support the SPP as yet for the dregs we are being offered short term opps elsewhere for my liking

I have a respectable holding just outside the top 20 took some off when i converted my oppis and invested elsewhere have already tripled that investment so was the correct decision

I do intend to stick around, just sick of supporting this guys wages that's all

I will be voting against the remuneration this year once more, just to voice my dissatisfaction on the arrogance of these people

Expand

Sam, unfortunately your rambling is terrible. Your grammar is as bad as the leaders mumbling. There's a saying put up or shut up.

ANP Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

3 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 12 more messages in this thread...

First 15 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change 0.000(0.00%)		Mkt cap ! $90.15M

Open	High	Low	Value	Volume
10.5¢	10.5¢	10.0¢	$47.27K	463.5K

Buyers (Bids)

No.	Vol.	Price($)
3	319942	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	86442	3

View Market Depth

No.	Vol.	Price($)
3	319942	0.100
3	113179	0.099
1	13000	0.098
2	130927	0.097
1	10004	0.096

Price($)	Vol.	No.
0.105	86442	3
0.110	290000	4
0.115	601850	5
0.120	275642	8
0.125	65000	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PER (ASX) Chart

Ann: Investor Presentation, page-15

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Investor Presentation, page-15

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The winners & losers on market if negative gearing were gone

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News